Developing the EPA guidance of pharmacological treatment of schizophrenia – results of a Delphi process
Abstract Background The development of guidelines is time-consuming and cost-intensive. The heterogeneity of clinical practice, evidence, and patients’ needs is an issue across Europe. An European core guidance for a specific psychiatric disorder may help to overcome this issue. Here, we present a...
Salvato in:
| Autori principali: | , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Cambridge University Press
2025-01-01
|
| Serie: | European Psychiatry |
| Soggetti: | |
| Accesso online: | https://www.cambridge.org/core/product/identifier/S0924933824017942/type/journal_article |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|